01 1Accord Healthcare Bv
02 1Accord Healthcare Slu
03 1Cipla Europe
04 1Cipla Europe Nv
05 1Laboratorio Reig Jofre Sa
06 1Reig Jofre Laboratory, Sa
07 1THE MEDICINES COMPANY UK LTD
08 2The Medic Ines Company UK Ltd
09 1The Medicines Company Uk Ltd
01 10Bivalirudin
01 1Bivalirudin 250Mg 10 Units Parenteral Use
02 4Injection/Infusion Solution
03 1Powder For Concentrate For Injectable Solution And For Infusion
04 1Powder For Concentrate For Injection And Infusion Solution
05 1Powder For Concentrate For Injection Or Infusion Solution
06 2Powder to concentrate to the Injection/infusion fluid, resolution
01 1Italy
02 2Norway
03 3Spain
04 4Sweden
01 4Angiox
02 1Bivalirudin Accord
03 1Bivalirudin Cipla
04 1Bivalirudin Reig Jofre
05 1Bivalirudina Accord
06 1Bivalirudina Cipla
07 1Bivalirudina Sala
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Bivalirudin Accord
Dosage Form : Injection/Infusion Solution
Dosage Strength : 250mg
Packaging :
Approval Date : 18/08/2016
Application Number : 20141205000168
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Bivalirudina Accord
Dosage Form : Powder For Concentrate For Injectable Solution And For Infusion
Dosage Strength : 250MG
Packaging :
Approval Date : 2016-12-23
Application Number : 81564
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Bivalirudin Cipla
Dosage Form : Injection/Infusion Solution
Dosage Strength : 250mg
Packaging :
Approval Date : 24/08/2016
Application Number : 20140926000082
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Bivalirudina Cipla
Dosage Form : Powder For Concentrate For Injection And Infusion Solution
Dosage Strength : 250MG
Packaging :
Approval Date : 2017-01-10
Application Number : 81587
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Bivalirudin Reig Jofre
Dosage Form : Injection/Infusion Solution
Dosage Strength : 250mg
Packaging :
Approval Date : 28/01/2016
Application Number : 20141129000015
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Bivalirudina Sala
Dosage Form : Powder For Concentrate For Injection Or Infusion Solution
Dosage Strength : 250MG
Packaging :
Approval Date : 2016-05-24
Application Number : 80912
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Deregistered
Registration Country : Sweden
Brand Name : Angiox
Dosage Form : Injection/Infusion Solution
Dosage Strength : 250mg
Packaging :
Approval Date : 20/09/2004
Application Number : 20040607004869
Regulatory Info : Deregistered
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Angiox
Dosage Form : Bivalirudin 250Mg 10 Units Parenteral Use
Dosage Strength : 10 VIALS EV 250 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Angiox
Dosage Form : Powder to concentrate to the Injection/infusion fluid, resolution
Dosage Strength : 250 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Angiox
Dosage Form : Powder to concentrate to the Injection/infusion fluid, resolution
Dosage Strength : 250 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
